Featured in Prurigo NodularisPrurigo Nodularis News & ResearchNemolizumab Improves Symptoms in Prurigo NodularisTreatment efficacy seen in primary end points of itch response and Investigator's Global Assessment responseBy Elana Gotkine (HealthDay News) | October 26, 2023 Itching, Sleep Disturbance Impact QoL in Prurigo NodularisAll patients with PN reported itch, pain associated with PN, bleeding or scabbing, and having dry skinBy Dermsquared Editorial Team | September 27, 2023Dupilumab Beneficial for Adults With Prurigo NodularisAll primary and key secondary end points met in two phase 3 trials of adults with PN with ≥20 nodulesBy Elana Gotkine (HealthDay News) | May 10, 2023